148 related articles for article (PubMed ID: 19457377)
1. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use.
Erritzoe D; Frokjaer VG; Haugbol S; Marner L; Svarer C; Holst K; Baaré WF; Rasmussen PM; Madsen J; Paulson OB; Knudsen GM
Neuroimage; 2009 May; 46(1):23-30. PubMed ID: 19457377
[TBL] [Abstract][Full Text] [Related]
2. Cerebral serotonin transporter binding is inversely related to body mass index.
Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM
Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236
[TBL] [Abstract][Full Text] [Related]
3. Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans.
Nomura M; Nomura Y
Ann N Y Acad Sci; 2006 Nov; 1086():134-43. PubMed ID: 17185512
[TBL] [Abstract][Full Text] [Related]
4. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
5. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.
Rylands AJ; Hinz R; Jones M; Holmes SE; Feldmann M; Brown G; McMahon AW; Talbot PS
Biol Psychiatry; 2012 Dec; 72(12):1004-11. PubMed ID: 22835812
[TBL] [Abstract][Full Text] [Related]
6. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
[TBL] [Abstract][Full Text] [Related]
7. 5HT2A receptor binding is increased in borderline personality disorder.
Soloff PH; Price JC; Meltzer CC; Fabio A; Frank GK; Kaye WH
Biol Psychiatry; 2007 Sep; 62(6):580-7. PubMed ID: 17448449
[TBL] [Abstract][Full Text] [Related]
8. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.
Rosell DR; Thompson JL; Slifstein M; Xu X; Frankle WG; New AS; Goodman M; Weinstein SR; Laruelle M; Abi-Dargham A; Siever LJ
Biol Psychiatry; 2010 Jun; 67(12):1154-62. PubMed ID: 20434136
[TBL] [Abstract][Full Text] [Related]
9. Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex.
Underwood MD; Mann JJ; Huang YY; Arango V
Alcohol Clin Exp Res; 2008 Apr; 32(4):593-9. PubMed ID: 18241316
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity.
Huang XF; Han M; Storlien LH
Brain Res Mol Brain Res; 2004 Aug; 127(1-2):39-47. PubMed ID: 15306119
[TBL] [Abstract][Full Text] [Related]
11. Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals.
Haahr ME; Hansen DL; Fisher PM; Svarer C; Stenbæk DS; Madsen K; Madsen J; Holst JJ; Baaré WF; Hojgaard L; Almdal T; Knudsen GM
J Neurosci; 2015 Apr; 35(14):5884-9. PubMed ID: 25855196
[TBL] [Abstract][Full Text] [Related]
12. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
[TBL] [Abstract][Full Text] [Related]
13. 5-HT2A receptor density is decreased in the at-risk mental state.
Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
[TBL] [Abstract][Full Text] [Related]
14. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
[TBL] [Abstract][Full Text] [Related]
15. Gender, personality, and serotonin-2A receptor binding in healthy subjects.
Soloff PH; Price JC; Mason NS; Becker C; Meltzer CC
Psychiatry Res; 2010 Jan; 181(1):77-84. PubMed ID: 19959344
[TBL] [Abstract][Full Text] [Related]
16. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
[TBL] [Abstract][Full Text] [Related]
17. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
[TBL] [Abstract][Full Text] [Related]
18. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
[TBL] [Abstract][Full Text] [Related]
19. The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.
Peremans K; Audenaert K; Hoybergs Y; Otte A; Goethals I; Gielen I; Blankaert P; Vervaet M; van Heeringen C; Dierckx R
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):708-16. PubMed ID: 15739093
[TBL] [Abstract][Full Text] [Related]
20. The influence of morphine on cerebral 5-HT2A availability in dogs: a SPECT study.
Adriaens AM; Polis IE; Vermeire ST; Waelbers T; Duchateau L; Sys SU; Van Dorpe S; Eersels JL; De Spiegeleer B; Peremans K
J Nucl Med; 2012 Dec; 53(12):1969-73. PubMed ID: 23090214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
